Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution
 Back to Profile

Daniel W. Golden

Concepts (268)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiation Oncology
35
2020
90
17.710
 Why?
Curriculum
17
2020
395
6.180
 Why?
Students, Medical
13
2020
287
4.690
 Why?
Clinical Clerkship
9
2018
101
4.520
 Why?
Internship and Residency
18
2020
809
3.610
 Why?
Education, Medical, Undergraduate
6
2019
135
2.470
 Why?
Program Evaluation
10
2020
282
2.430
 Why?
Needs Assessment
5
2019
123
2.230
 Why?
Chemoradiotherapy
6
2020
235
2.210
 Why?
Career Choice
7
2020
122
2.190
 Why?
Clinical Competence
8
2019
645
2.110
 Why?
Medical Oncology
4
2019
285
1.960
 Why?
Radiotherapy Planning, Computer-Assisted
7
2019
154
1.700
 Why?
Educational Measurement
8
2019
199
1.560
 Why?
Education, Medical, Graduate
5
2019
291
1.530
 Why?
Reading
2
2019
31
1.480
 Why?
Health Literacy
2
2019
44
1.410
 Why?
Patient Education as Topic
3
2019
323
1.370
 Why?
School Admission Criteria
2
2016
20
1.270
 Why?
Internet
5
2018
300
1.090
 Why?
Interdisciplinary Studies
2
2019
21
1.040
 Why?
Brachytherapy
2
2020
102
1.020
 Why?
Interprofessional Relations
2
2019
107
1.000
 Why?
Uterine Cervical Neoplasms
2
2020
222
0.980
 Why?
United States
18
2020
5574
0.960
 Why?
Schools, Medical
2
2019
106
0.950
 Why?
Humans
60
2020
75301
0.950
 Why?
Adenocarcinoma
3
2019
1196
0.850
 Why?
Radiotherapy Dosage
4
2019
441
0.840
 Why?
Radiotherapy, Image-Guided
2
2016
51
0.790
 Why?
Carcinoma, Squamous Cell
3
2020
1002
0.750
 Why?
Elbow Joint
2
2008
31
0.740
 Why?
Range of Motion, Articular
2
2008
141
0.710
 Why?
Patient Care Team
1
2019
245
0.710
 Why?
Nasopharyngeal Neoplasms
2
2016
43
0.710
 Why?
Patient-Centered Care
1
2019
164
0.700
 Why?
Academic Medical Centers
2
2018
357
0.670
 Why?
Carcinoma, Non-Small-Cell Lung
3
2019
873
0.660
 Why?
Neoplasms
3
2019
2362
0.640
 Why?
Pamphlets
1
2015
14
0.640
 Why?
Teaching
1
2016
139
0.630
 Why?
Fluorouracil
3
2016
571
0.600
 Why?
Female
28
2020
41483
0.590
 Why?
Radiosurgery
3
2013
198
0.580
 Why?
Pediatrics
1
2018
331
0.570
 Why?
Radiotherapy, Conformal
2
2016
80
0.560
 Why?
Health Knowledge, Attitudes, Practice
1
2018
477
0.550
 Why?
Lung Neoplasms
4
2019
1993
0.550
 Why?
CA-19-9 Antigen
1
2012
13
0.540
 Why?
Pilot Projects
4
2020
736
0.530
 Why?
Male
25
2020
39121
0.520
 Why?
Carcinoma
2
2012
429
0.510
 Why?
Adult
18
2020
24240
0.510
 Why?
Research
2
2013
248
0.510
 Why?
Induction Chemotherapy
1
2012
113
0.500
 Why?
Prostatic Neoplasms
2
2019
1333
0.450
 Why?
Young Adult
7
2019
5341
0.420
 Why?
Incidental Findings
2
2020
96
0.420
 Why?
Lymphatic Metastasis
3
2020
491
0.410
 Why?
Ulna
1
2007
12
0.370
 Why?
Humerus
1
2007
25
0.370
 Why?
Comprehension
2
2019
67
0.370
 Why?
Overweight
1
2008
102
0.360
 Why?
Pancreatic Neoplasms
1
2012
681
0.340
 Why?
Data Collection
3
2018
361
0.340
 Why?
Neoplasm Staging
5
2019
1867
0.310
 Why?
Body Mass Index
1
2008
709
0.300
 Why?
Brain Neoplasms
2
2014
758
0.290
 Why?
Aged
10
2019
17101
0.290
 Why?
Radiotherapy, Adjuvant
2
2019
302
0.290
 Why?
Child
7
2018
6125
0.280
 Why?
Teaching Rounds
2
2020
20
0.270
 Why?
Chicago
2
2018
1292
0.240
 Why?
Chi-Square Distribution
2
2020
387
0.240
 Why?
Second-Look Surgery
1
2020
4
0.240
 Why?
Faculty, Medical
2
2020
153
0.240
 Why?
Hemoglobin A
1
2020
9
0.240
 Why?
Middle Aged
12
2020
23980
0.240
 Why?
Chemotherapy, Adjuvant
2
2012
467
0.240
 Why?
Mentors
2
2019
56
0.230
 Why?
Information Seeking Behavior
1
2020
7
0.230
 Why?
Hysterectomy
1
2020
78
0.230
 Why?
Vaccines, DNA
1
2020
13
0.230
 Why?
Human papillomavirus 18
1
2020
15
0.230
 Why?
Program Development
3
2019
126
0.230
 Why?
Human papillomavirus 16
1
2020
30
0.220
 Why?
Mediastinum
1
2019
46
0.210
 Why?
Nurse Practitioners
1
2019
20
0.210
 Why?
Safety
1
2020
163
0.210
 Why?
Models, Educational
1
2019
50
0.210
 Why?
Self-Assessment
1
2018
47
0.210
 Why?
Neoplasm Invasiveness
1
2020
511
0.200
 Why?
Training Support
1
2018
19
0.200
 Why?
Time Factors
5
2020
5245
0.200
 Why?
Cross-Sectional Studies
4
2020
1192
0.200
 Why?
Neoplasm Recurrence, Local
3
2017
1082
0.200
 Why?
Patient Simulation
1
2018
40
0.200
 Why?
Manikins
1
2018
36
0.200
 Why?
Postoperative Care
1
2019
229
0.200
 Why?
Workload
1
2019
111
0.190
 Why?
Computer-Assisted Instruction
1
2018
44
0.190
 Why?
Survival Rate
3
2012
1852
0.190
 Why?
Retrospective Studies
7
2019
6435
0.190
 Why?
Hospitals, Teaching
2
2019
120
0.190
 Why?
Solitary Pulmonary Nodule
1
2019
170
0.190
 Why?
Prostate-Specific Antigen
1
2019
295
0.190
 Why?
Ethics, Medical
1
2020
301
0.180
 Why?
Universities
1
2018
118
0.180
 Why?
Medical Illustration
1
2016
13
0.180
 Why?
Pneumonectomy
1
2019
166
0.180
 Why?
Job Satisfaction
1
2017
59
0.180
 Why?
Leukopenia
1
2016
64
0.180
 Why?
Anus Neoplasms
1
2016
24
0.180
 Why?
Radiation Injuries
2
2016
159
0.180
 Why?
Treatment Outcome
6
2017
7300
0.180
 Why?
General Surgery
1
2019
197
0.180
 Why?
Consensus
2
2016
235
0.170
 Why?
Pelvic Bones
1
2016
35
0.170
 Why?
Texas
1
2016
75
0.170
 Why?
Early Detection of Cancer
1
2019
262
0.170
 Why?
Bronchi
1
2017
228
0.170
 Why?
Endosonography
1
2017
124
0.170
 Why?
Thrombocytopenia
1
2016
150
0.170
 Why?
Radiation, Ionizing
2
2014
120
0.170
 Why?
Societies, Medical
2
2019
477
0.170
 Why?
Aged, 80 and over
5
2017
6136
0.170
 Why?
Erythrocyte Transfusion
2
2010
47
0.170
 Why?
Kaplan-Meier Estimate
3
2013
865
0.170
 Why?
Radiotherapy, Intensity-Modulated
2
2016
148
0.160
 Why?
Dose-Response Relationship, Radiation
2
2012
203
0.160
 Why?
Lymph Nodes
1
2019
507
0.160
 Why?
Bone Marrow
1
2016
406
0.160
 Why?
Breast Neoplasms
3
2016
2567
0.150
 Why?
Esophagitis
1
2014
42
0.150
 Why?
Radiotherapy
1
2016
334
0.150
 Why?
Boston
1
2014
35
0.150
 Why?
Job Application
1
2013
8
0.150
 Why?
RNA Helicases
1
2014
36
0.150
 Why?
Radiation-Sensitizing Agents
1
2014
106
0.140
 Why?
Follow-Up Studies
4
2017
3613
0.140
 Why?
Personnel Selection
1
2014
50
0.140
 Why?
Adolescent
4
2012
8442
0.140
 Why?
Self Concept
1
2014
126
0.140
 Why?
DEAD-box RNA Helicases
1
2014
72
0.140
 Why?
Child, Preschool
4
2010
3571
0.140
 Why?
Metalloporphyrins
1
2012
26
0.140
 Why?
Social Networking
1
2013
56
0.140
 Why?
Sirolimus
1
2014
165
0.140
 Why?
Skin
1
2016
535
0.140
 Why?
Platinum
1
2012
45
0.130
 Why?
Disease-Free Survival
2
2013
1190
0.130
 Why?
Hydroxyurea
1
2012
229
0.130
 Why?
Adrenal Gland Neoplasms
1
2013
99
0.130
 Why?
Education, Medical
1
2014
196
0.130
 Why?
Carcinoma, Large Cell
1
2012
40
0.130
 Why?
Neoplasms, Experimental
1
2014
281
0.130
 Why?
Quality Improvement
1
2014
305
0.120
 Why?
Deoxycytidine
1
2012
239
0.120
 Why?
Cell Survival
1
2014
993
0.120
 Why?
Remission Induction
1
2012
668
0.120
 Why?
Sensitivity and Specificity
1
2016
2046
0.120
 Why?
Genetic Vectors
1
2012
437
0.120
 Why?
Neoadjuvant Therapy
1
2012
244
0.120
 Why?
Exhalation
1
2010
4
0.120
 Why?
Hemoglobinopathies
1
2010
10
0.110
 Why?
Carcinoma, Renal Cell
1
2013
344
0.110
 Why?
Carbon Monoxide
1
2010
87
0.110
 Why?
Thyroid Neoplasms
1
2014
408
0.110
 Why?
STAT1 Transcription Factor
1
2009
48
0.110
 Why?
Reproducibility of Results
1
2016
2605
0.110
 Why?
Benzimidazoles
1
2010
130
0.110
 Why?
Canada
2
2020
188
0.100
 Why?
Kidney Neoplasms
1
2013
529
0.100
 Why?
Lifting
1
2008
5
0.100
 Why?
Elbow
1
2008
12
0.100
 Why?
Tumor Necrosis Factor-alpha
1
2012
663
0.100
 Why?
Disease Progression
1
2012
1354
0.100
 Why?
Salaries and Fringe Benefits
2
2020
18
0.090
 Why?
Cohort Studies
2
2017
2426
0.090
 Why?
Physicians
1
2014
540
0.090
 Why?
Folic Acid
1
2007
45
0.090
 Why?
Linear Models
1
2008
419
0.090
 Why?
Enzyme Inhibitors
1
2010
665
0.090
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2016
2133
0.080
 Why?
Prospective Studies
4
2020
3554
0.080
 Why?
Chromosome Aberrations
1
2007
393
0.080
 Why?
Anemia, Sickle Cell
2
2010
112
0.080
 Why?
Prognosis
2
2012
3424
0.080
 Why?
Melanoma
1
2008
461
0.070
 Why?
Infant
2
2007
2924
0.070
 Why?
Age Factors
1
2007
1822
0.060
 Why?
Colitis, Ulcerative
1
2007
598
0.060
 Why?
Crohn Disease
1
2007
639
0.060
 Why?
Iron Overload
1
2000
4
0.060
 Why?
Papillomavirus E7 Proteins
1
2020
25
0.060
 Why?
Oncogene Proteins, Viral
1
2020
30
0.060
 Why?
Sex Distribution
1
2020
166
0.060
 Why?
Personal Satisfaction
1
2020
47
0.050
 Why?
Personnel Delegation
1
2019
1
0.050
 Why?
Iron
1
2000
156
0.050
 Why?
Advisory Committees
1
2019
83
0.050
 Why?
Preventive Health Services
1
2019
47
0.050
 Why?
Trauma Centers
1
2019
75
0.050
 Why?
Risk Factors
1
2008
4896
0.050
 Why?
Interdisciplinary Communication
1
2019
130
0.050
 Why?
Organs at Risk
1
2016
34
0.040
 Why?
Mitomycin
1
2016
38
0.040
 Why?
Ilium
1
2016
18
0.040
 Why?
Parotid Gland
1
2016
29
0.040
 Why?
Cochlea
1
2016
46
0.040
 Why?
Repressor Proteins
1
2020
371
0.040
 Why?
Sex Factors
1
2020
1044
0.040
 Why?
Neutropenia
1
2016
215
0.040
 Why?
Tumor Burden
1
2016
267
0.040
 Why?
Incidence
1
2019
1503
0.040
 Why?
Feasibility Studies
1
2016
682
0.040
 Why?
Decision Making
1
2020
572
0.040
 Why?
Drug Administration Schedule
1
2016
951
0.040
 Why?
Physician-Patient Relations
1
2020
566
0.040
 Why?
Mastectomy
1
2016
204
0.040
 Why?
Apoptosis
2
2014
1722
0.040
 Why?
Family Characteristics
1
2013
43
0.040
 Why?
Fatal Outcome
1
2014
297
0.040
 Why?
DNA-Binding Proteins
1
2020
1150
0.030
 Why?
Mice
3
2014
10400
0.030
 Why?
Survival Analysis
1
2017
1550
0.030
 Why?
Interferon Type I
1
2014
170
0.030
 Why?
Fatigue
1
2013
160
0.030
 Why?
Tumor Cells, Cultured
1
2014
1084
0.030
 Why?
Glioblastoma
1
2014
232
0.030
 Why?
Carcinoma, Hepatocellular
1
2014
275
0.030
 Why?
Infrared Rays
1
2010
16
0.030
 Why?
Cell Growth Processes
1
2010
83
0.030
 Why?
Thalassemia
1
2010
17
0.030
 Why?
Breath Tests
1
2010
52
0.030
 Why?
Neuroblastoma
1
2014
441
0.030
 Why?
Green Fluorescent Proteins
1
2010
311
0.030
 Why?
Liver Neoplasms
1
2014
589
0.030
 Why?
Xenograft Model Antitumor Assays
1
2010
421
0.030
 Why?
Mice, Knockout
1
2014
1826
0.030
 Why?
Neoplasm Transplantation
1
2009
396
0.020
 Why?
Melanoma, Experimental
1
2009
104
0.020
 Why?
Doxorubicin
1
2009
294
0.020
 Why?
Mice, Nude
1
2010
762
0.020
 Why?
Recombinant Fusion Proteins
1
2010
560
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
358
0.020
 Why?
Micronucleus Tests
1
2007
6
0.020
 Why?
Animals
3
2014
25499
0.020
 Why?
Interferon-gamma
1
2009
427
0.020
 Why?
Longitudinal Studies
1
2010
865
0.020
 Why?
Combined Modality Therapy
1
2010
1608
0.020
 Why?
Image Processing, Computer-Assisted
1
2012
1150
0.020
 Why?
Predictive Value of Tests
1
2010
1582
0.020
 Why?
Neoplasm Metastasis
1
2009
1001
0.020
 Why?
Antineoplastic Agents
1
2016
2280
0.020
 Why?
Lymphocytes
1
2007
460
0.020
 Why?
Cell Line, Tumor
1
2010
2306
0.020
 Why?
Transcription, Genetic
1
2009
1127
0.020
 Why?
Lung
1
2009
1002
0.020
 Why?
Phenotype
1
2009
2098
0.020
 Why?
Epithelial Cells
1
2007
589
0.020
 Why?
Mice, Inbred C57BL
1
2009
2962
0.020
 Why?
Hemoglobin, Sickle
1
2000
16
0.010
 Why?
Ferritins
1
2000
27
0.010
 Why?
Splenectomy
1
2000
92
0.010
 Why?
Signal Transduction
1
2009
3174
0.010
 Why?
Biopsy
1
2000
1108
0.010
 Why?
Liver
1
2000
1185
0.010
 Why?
Golden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (268) concept(s)
_
Co-Authors Expand Description
See all (41) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_